A C E Scowcroft1, M R Cowie2. 1. Boehringer Ingelheim, Ellesfield Avenue, Bracknell, Berkshire RG12 8YS, UK. 2. National Heart & Lung Institute, Imperial College London, Dovehouse Street, London SW3 6LY, UK. Electronic address: m.cowie@imperial.ac.uk.
Abstract
OBJECTIVE: To investigate recent trends in the diagnosis and treatment of atrial fibrillation. METHODS: Time trend analysis in the UK Clinical Practice Research Datalink (CPRD -previously the GPRD), 2000-2012. RESULTS: The incidence of AF in men rose from 1.274 (1.271, 1.276) per 1 000 patient years in 2000 to 1.972 (1.969, 1.975) in 2012. In women, it rose from 1.209 (1.207, 1.211) to 1.609 (1.606, 1.611). 55847 patients with AF first diagnosed between 2000 and 2012 were included in the study. 54% of men were initiated on anticoagulation therapy in the first year following diagnosis of atrial fibrillation, compared to 45% of women (P<0.0001). This increased from 48% in men and 40% in women in 2000 to 58% in men and 52% in women in 2012. CONCLUSIONS: Identification of atrial fibrillation has improved in recent years, as has treatment for stroke prevention. Although there has historically been a bias towards men in the treatment of stroke prevention in atrial fibrillation, this study shows that the gap has been closing in recent years. Despite this improvement, this study shows that there are still many patients with atrial fibrillation who are not treated optimally to prevent stroke.
OBJECTIVE: To investigate recent trends in the diagnosis and treatment of atrial fibrillation. METHODS: Time trend analysis in the UK Clinical Practice Research Datalink (CPRD -previously the GPRD), 2000-2012. RESULTS: The incidence of AF in men rose from 1.274 (1.271, 1.276) per 1 000 patient years in 2000 to 1.972 (1.969, 1.975) in 2012. In women, it rose from 1.209 (1.207, 1.211) to 1.609 (1.606, 1.611). 55847 patients with AF first diagnosed between 2000 and 2012 were included in the study. 54% of men were initiated on anticoagulation therapy in the first year following diagnosis of atrial fibrillation, compared to 45% of women (P<0.0001). This increased from 48% in men and 40% in women in 2000 to 58% in men and 52% in women in 2012. CONCLUSIONS: Identification of atrial fibrillation has improved in recent years, as has treatment for stroke prevention. Although there has historically been a bias towards men in the treatment of stroke prevention in atrial fibrillation, this study shows that the gap has been closing in recent years. Despite this improvement, this study shows that there are still many patients with atrial fibrillation who are not treated optimally to prevent stroke.
Authors: Katherine I Morley; Joshua Wallace; Spiros C Denaxas; Ross J Hunter; Riyaz S Patel; Pablo Perel; Anoop D Shah; Adam D Timmis; Richard J Schilling; Harry Hemingway Journal: PLoS One Date: 2014-11-04 Impact factor: 3.240
Authors: Deirdre A Lane; Flemming Skjøth; Gregory Y H Lip; Torben B Larsen; Dipak Kotecha Journal: J Am Heart Assoc Date: 2017-04-28 Impact factor: 5.501
Authors: Emma L Veale; Adrian J Stewart; Alistair Mathie; Satvinder K Lall; Melanie Rees-Roberts; Vilius Savickas; Sukvinder K Bhamra; Sarah A Corlett Journal: BMJ Open Date: 2018-03-14 Impact factor: 2.692